Kiplinger Dividend 15: CVS Interrupts Its String of Hikes
After raising its payout for 14 years straight, the pharmacy ended its streak in 2018.
Since we last updated the Kiplinger Dividend 15, the list of our favorite dividend-paying stocks, volatility has ruled the market. Despite the ups and downs, Standard & Poor’s 500-stock index has returned 11.9%, including dividends, since we launched the Dividend 15 in our December issue. By comparison, our collection returned an average of 5.4%. Of course, these stocks were chosen for their stable payouts, income growth or above-average yields, not their ability to outpace the market. (Prices and returns are through June 15.)
That said, a handful of the Dividend 15 beat the S&P 500. Texas Instruments (TXN) returned 31.6%, thanks to strong demand for its chips. Home Depot, helped by a strong housing market, returned 24.6%. Shares in Emerson Electric, which makes electrical and electronic products, have returned 17.5%. And Enterprise Products Partners, which runs oil and gas pipelines, posted a 12.9% gain.
Still, two consumer-products giants have been a drag on the group. Johnson & Johnson (JNJ) shares fell 3.8%, and Procter & Gamble dropped 12.8%. But we’re upbeat about the pair with regard to both their dividends and their solid prospects overall. Johnson & Johnson raised its quarterly payout by 7% in April. The company, says CFRA analyst Jeffrey Loo, has “unmatched depth and breadth in growing global health care markets and solid positions in drugs, medical devices and consumer products.” Procter & Gamble (PG) lifted its quarterly dividend by 4% in April, and analysts expect the company to report 7% earnings growth in 2018.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
A Long Streak Ends
CVS Health (CVS) was a laggard, too. The stock sank 12.0%. What’s more, despite expectations that the firm would continue its history of robust dividend hikes, it did not raise its payout for 2018, ending a 14-year record of consecutive annual increases. Analysts say a freeze of the dividend at current levels is a possibility following CVS’s deal to buy insurer Aetna for $69 billion. The merger, okayed by shareholders, still needs regulatory approval. If it goes through, a broader customer base will make CVS more competitive, says Value Line analyst Andre J. Costanza. And if regulators nix the deal, CVS should still deliver solid results. We’re keeping CVS in the Dividend 15 for now, but we are watching its dividend policy. Our other dividend growers are on track: Home Depot, Lockheed Martin and Texas Instruments have increased their annual payouts by double-digit percentages over their most recent fiscal years.
That brings us to Realty Income (O). Rising interest rates have put pressure on real estate investment trusts. Borrowing to buy new properties has become harder for REIT managers, and other investments’ yields have become more competitive. Since we launched the Dividend 15, Realty Income shares have lost 4.3%, while the S&P 500 Real Estate sector index was flat. Even so, Realty Income’s business is humming along. Revenue for the quarter ended in March rose 7% from the same quarter a year ago, and funds from operations (a profit measure roughly equivalent to earnings) climbed 20%. Plus, Realty Income yields 5%, more than the typical REIT yield of 4.1%.
To continue reading this article
please register for free
This is different from signing in to your print subscription
Why am I seeing this? Find out more here
Nellie joined Kiplinger in August 2011 after a seven-year stint in Hong Kong. There, she worked for the Wall Street Journal Asia, where as lifestyle editor, she launched and edited Scene Asia, an online guide to food, wine, entertainment and the arts in Asia. Prior to that, she was an editor at Weekend Journal, the Friday lifestyle section of the Wall Street Journal Asia. Kiplinger isn't Nellie's first foray into personal finance: She has also worked at SmartMoney (rising from fact-checker to senior writer), and she was a senior editor at Money.
-
Is a Phased Retirement Right for You?
Want to keep working, just not as hard? A phased retirement may just be the answer.
By Kimberly Lankford Published
-
Four Tips to Make Your Sales Presentation a Winner
Being prepared and not being boring can go a long way toward persuading a potential customer to buy into what you’re offering.
By H. Dennis Beaver, Esq. Published
-
Stock Market Today: Markets Rebound Ahead of Big Week for Earnings
Equities rallied on easing geopolitical tensions, upcoming quarterly results.
By Dan Burrows Published
-
Stock Market Today: Nasdaq Spirals as Netflix Nosedives
A big earnings boom for credit card giant American Express helped the Dow notch another win.
By Karee Venema Published
-
Stock Market Today: S&P 500, Nasdaq Extend Losing Streaks
The two indexes have closed lower for five straight sessions.
By Karee Venema Published
-
Stock Market Today: Dow Slips After Travelers' Earnings Miss
The property and casualty insurer posted a bottom-line miss as catastrophe losses spiked.
By Karee Venema Published
-
Stock Market Today: Stocks Stabilize After Powell's Rate-Cut Warning
The main indexes temporarily tumbled after Fed Chair Powell said interest rates could stay higher for longer.
By Karee Venema Published
-
Stock Market Today: Stocks Reverse Lower as Treasury Yields Spike
A good-news-is-bad-news retail sales report lowered rate-cut expectations and caused government bond yields to surge.
By Karee Venema Last updated
-
Stock Market Today: Nasdaq Leads as Magnificent 7 Stocks Rise
Strength in several mega-cap tech and communication services stocks kept the main indexes higher Thursday.
By Karee Venema Published
-
Stock Market Today: Stocks Tumble After a Hot Inflation Print
Equities retreated after inflation data called the Fed's rate-cut plans into question.
By Dan Burrows Published